Ncardia Services
Latest round
- Series B
Last raised
- Nov 2017
Total raised
- $12M
Investors
- 6
About Ncardia Services
V.V. and Axiogenesis AG. The firm operates as a stem cell drug discovery and development company.V. The company collaborates with biopharmaceutical businesses to develop new treatments for a variety of modalities at any stage of development by utilizing the power of stem cell technologies in drug discovery and cell therapy. The business's focus is on the creation and production of human induced pluripotent stem cell (hiPSC)-derived goods and services for drug discovery, safety pharmacology, and disease modeling.
Who invested in Ncardia Services
6 investors across 1 round
See all investors in Ncardia Services
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Nov 17, 2017
Amount
$12M
Investors
Questions about Ncardia Services
Who invested in Ncardia Services?
Ncardia Services has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ncardia Services raised?
Ncardia Services has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ncardia Services last raise money?
Ncardia Services's most recent round on record is a Series B, in Nov 2017.
What does Ncardia Services do?
Ncardia Services is a biotechnology company.
Where is Ncardia Services headquartered?
Ncardia Services is headquartered in Netherlands.
Which VCs invest in companies like Ncardia Services?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Ncardia Services's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Ncardia Services? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.